This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Company Statement: Teva and Cephalon receive European Commission approval for acquisition

( October 13, 2011, 20:02 GMT | Official Statement) -- MLex Summary: Israeli company Teva announced that it has received conditional merger clearance from the European Commission for its planned acquisition of US biopharmaceutical company Cephalon. Teva has to divest Cephalon's marketing authorization of generic modafinil in France and grant also some additional rights in the entire European Economic Area. The parties expect to close the deal tomorrow, 14 October.Company statement follows in full:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login